Contemporary use of beta receptor antagonists in chronic heart failure

Ravi K. Garg; A. Nasser Khan; Allen S. Anderson

doi:10.1007/s12019-002-0019-7

Contemporary use of beta receptor antagonists in chronic heart failure

Ravi K. Garg, A. Nasser Khan, Allen S. Anderson^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

β-adrenergic receptor antagonists slow disease progression, improve symptoms, and increase survival. They should be considered standard of care for patients with stable heart failure and understanding which drugs provide benefit and how to initiate therapy is crucial to improving prognosis.

Original language	English (US)
Pages (from-to)	207-213
Number of pages	7
Journal	Comprehensive therapy
Volume	28
Issue number	4
DOIs	https://doi.org/10.1007/s12019-002-0019-7
State	Published - Jan 1 2002

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/s12019-002-0019-7

Cite this

@article{84f96f151bf44ee0a35cc1b0422f43a7,

title = "Contemporary use of beta receptor antagonists in chronic heart failure",

abstract = "β-adrenergic receptor antagonists slow disease progression, improve symptoms, and increase survival. They should be considered standard of care for patients with stable heart failure and understanding which drugs provide benefit and how to initiate therapy is crucial to improving prognosis.",

author = "Garg, {Ravi K.} and Khan, {A. Nasser} and Anderson, {Allen S.}",

year = "2002",

month = jan,

day = "1",

doi = "10.1007/s12019-002-0019-7",

language = "English (US)",

volume = "28",

pages = "207--213",

journal = "Comprehensive therapy",

issn = "0098-8243",

publisher = "Humana Press",

number = "4",

}

TY - JOUR

T1 - Contemporary use of beta receptor antagonists in chronic heart failure

AU - Garg, Ravi K.

AU - Khan, A. Nasser

AU - Anderson, Allen S.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - β-adrenergic receptor antagonists slow disease progression, improve symptoms, and increase survival. They should be considered standard of care for patients with stable heart failure and understanding which drugs provide benefit and how to initiate therapy is crucial to improving prognosis.

AB - β-adrenergic receptor antagonists slow disease progression, improve symptoms, and increase survival. They should be considered standard of care for patients with stable heart failure and understanding which drugs provide benefit and how to initiate therapy is crucial to improving prognosis.

UR - http://www.scopus.com/inward/record.url?scp=0036917662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036917662&partnerID=8YFLogxK

U2 - 10.1007/s12019-002-0019-7

DO - 10.1007/s12019-002-0019-7

M3 - Article

C2 - 12506490

AN - SCOPUS:0036917662

SN - 0098-8243

VL - 28

SP - 207

EP - 213

JO - Comprehensive therapy

JF - Comprehensive therapy

IS - 4

ER -

Contemporary use of beta receptor antagonists in chronic heart failure

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this